Methodology in improving antibiotic implementation policies ,
, Methodol, vol.6, pp.143-153, 2016.
New perspectives on 477 the use of phytochemicals as an emergent strategy to control bacterial infections 478 including biofilms, Molecules, vol.21, p.877, 2016. ,
Lichens: a promising source of antibiotic and anticancer 480 drugs, Phytochem. Rev, vol.12, pp.229-244, 2013. ,
Lichens-a promising source of bioactive secondary metabolites, p.482 ,
, Plant Genet. Resour. Charact. Util, vol.3, pp.273-287, 2005.
Lichens as a potential natural source of bioactive 484 compounds: a review, Phytochem. Rev, vol.9, pp.303-314, 2010. ,
Lichen 487 secondary metabolites are responsible for induction of apoptosis in HT-29 and A2780 488 human cancer cell lines, Toxicol. Vitro Int. J. Publ. Assoc. BIBRA, vol.26, pp.462-468, 2012. ,
, , p.491
Design, synthesis and biological evaluation of potential 492 antibacterial butyrolactones, Bioorg. Med. Chem, vol.24, 2016. ,
Porphyromonas gingivalis: An Overview of 495 ,
, Periodontopathic Pathogen below the Gum Line, Front. Microbiol, vol.7, 2016.
,
, Oral Streptococci, p.499
, Biofilm Formation on Different Implant Surface Topographies, vol.500, p.159625, 2015.
Bacterial 502 interactions in pathogenic subgingival plaque, Microb. Pathog, vol.94, pp.60-69, 2016. ,
,
Antibiotic development challenges: the various mechanisms of action of 506 antimicrobial peptides and of bacterial resistance, Front. Microbiol, vol.4, 2013. ,
Recent advances in the formation of the bacterial peptidoglycan 509 monomer unit, Nat. Prod. Rep, vol.18, pp.503-519, 2001. ,
From the regulation of peptidoglycan 511 synthesis to bacterial growth and morphology, Nat. Rev. Microbiol, vol.10, pp.123-136, 2011. ,
Targeting bacterial membrane function: 514 an underexploited mechanism for treating persistent infections, Nat. Rev. Microbiol, vol.9, pp.62-75, 2011. ,
Drug resistance of bacterial dental biofilm 517 and the potential use of natural compounds as alternative for prevention and treatment, p.518 ,
, Microb. Pathog, vol.80, pp.39-49, 2015.
Platforms for antibiotic discovery, Nat. Rev. Drug Discov, vol.12, pp.371-520, 2013. ,
Synthesis of Fluorescent Probes Based 522 on the Pyochelin Siderophore Scaffold, Org. Lett, vol.13, pp.844-847, 2011. ,
A periodontitis-associated 525 multispecies model of an oral biofilm, J. Periodontal Implant Sci, vol.44, 2014. ,
Antibacterial mechanisms of 528 rhodomyrtone against important hospital-acquired antibiotic-resistant pathogenic 529 bacteria, J. Med. Microbiol, vol.62, pp.78-85, 2013. ,
,
Searching for the Optimal Fluorophore to Label Antimicrobial Peptides, ACS 532 Comb. Sci, vol.18, pp.689-696, 2016. ,
,
Fluorescently labeled macrolides as a tool for 535 monitoring cellular and tissue distribution of azithromycin, Pharmacol. Res, vol.66, pp.332-342, 2012. ,
An unprecedented 538 alteration in mode of action of IsCT resulting its translocation into bacterial cytoplasm 539 and inhibition of macromolecular syntheses, Sci. Rep, vol.5, 2015. ,
Molecular evolution of animal antimicrobial peptides: widespread 542 moderate positive selection, J. Evol. Biol, vol.18, pp.1387-1394, 2005. ,
Fluorescence labeling and microscopy of DNA, Methods 545 Cell Biol, vol.30, pp.417-448, 1989. ,
Lichen secondary metabolite evernic acid as potential quorum 547 sensing inhibitor against <i>Pseudomonas aeruginosa<i/>, World J. Microbiol ,
, Biotechnol, vol.32, 2016.
Gram-positive bacterial cell envelopes: The impact on the 550 activity of antimicrobial peptides, Biochim. Biophys. Acta, vol.1858, pp.936-946, 2016. ,
,
Membrane-damaging potential of natural L-(-)-usnic acid in 554 ,
, Staphylococcus aureus, Eur. J. Clin. Microbiol. Infect. Dis. Off. Publ. Eur. Soc. Clin
, , vol.31, pp.3375-3383, 2012.
Letharia vulpina, a vulpinic acid 557 containing lichen, targets cell membrane and cell division processes in methicillin-558 resistant Staphylococcus aureus, Pharm. Biol, vol.54, pp.413-418, 2016. ,